Canada Ventilator Market Overview, 2031

Numerous respiratory conditions have increased as a result of rising pollution levels, tobacco use, unhealthful lifestyle choices, and dietary patterns. Lung cancer, acute lower respiratory tract infections, asthma, chronic obstructive pulmonary disease COPD, and TB are among the most frequent respiratory conditions that cause serious illness and death. Acute respiratory failure brought on by these illnesses needs to be treated with mechanical ventilation. There will probably be a greater need for ventilators in Canada due to the rising incidence of respiratory illnesses there. The government reports that as of August 27, 2020, there were 9,094 fatalities from Corona virus infection and 126,417 instances of the virus. The Canadian Chronic Disease Surveillance System's 2018 study, Asthma and Chronic Obstructive Pulmonary Disease COPD in Canada, states that over 3.5 million adults over the age of one have asthma, and over 2 million have chronic obstructive pulmonary disease COPD. Because of this, it is anticipated that there will be a huge need for ventilators during the pandemic. Ventilator demand is therefore rising due to the increased number of patients afflicted by the pandemic and the rising frequency of respiratory disorders, which is driving market potential. The COVID-19 pandemic has underscored the importance of ventilators, and like many other countries, Canada experienced an increased demand for these devices during the pandemic. Efforts were made to enhance the ventilator supply to meet the needs of patients in various provinces. Canada has a publicly funded healthcare system that provides universal access to medical services. The procurement and distribution of medical equipment, including ventilators, are influenced by federal and provincial healthcare authorities.

According to the research report, " Canada Ventilator Market Overview, 2031," published by Bonafide Research, the Canada Ventilator market is expected to reach a market size of more than USD 216.15 Million by 2031. Canada places a strong emphasis on research and development in the healthcare sector. Innovations in ventilator technology and design emerge from Canadian research institutions and companies, contributing to advancements in respiratory care. As in many other countries, there is a growing interest in telehealth services in Canada. This includes the use of remote monitoring technologies for patients using ventilators at home, allowing healthcare professionals to track patient status and adjust treatment plans as needed. Trends in population health, such as the prevalence of respiratory conditions or chronic diseases, can influence the demand for ventilators. An ageing population and lifestyle factors contribute to respiratory health challenges. Recently, there have been smart ventilators, and connectivity is in demand. That is, the integration of smart technologies into ventilators allows for real-time monitoring and data collection. Furthermore, remote monitoring and telehealth include enhanced capabilities for remote monitoring, allowing healthcare providers to track patients using ventilators from a distance. These types of trends are growing in the market. The demand for ventilators is influenced by the capacity of hospitals and critical care units. Adequate numbers of ventilators are essential to meet the needs of patients in intensive care settings. Advancements in ventilator technology, including features like smart capabilities, improved user interfaces, and adaptive ventilation modes, can drive demand as healthcare providers seek to upgrade their equipment.

Canada ventilator market by product type is divided into intensive care ventilators, portable/transport ventilators and others. In Canada, the market for ventilators, categorized by product type, is mostly fueled by intensive care ventilators, portable/transport ventilators, and various specialized systems. The largest portion belongs to intensive care ventilators, which play a vital role in hospital ICUs for treating severe respiratory issues like acute respiratory distress syndrome ARDS, chronic obstructive pulmonary disease COPD, and respiratory failure after surgery. Hospitals across Canada are continuously investing in state-of-the-art ICU ventilators that offer features such as adaptive ventilation modes, built-in monitoring, and compatibility with electronic health records EHR to enhance patient outcomes and increase operational efficiency. The impact of the COVID-19 pandemic has stressed the necessity of maintaining sufficient ICU ventilator capacity throughout provinces, leading both public and private healthcare organizations to focus on replacement and upgrades. Portable and transport ventilators are a growing segment, driven by Canada’s extensive geography and the necessity for transferring patients between facilities, air ambulance operations, and emergency medical services EMS. These ventilators are made for robustness, lightweight design, and battery efficiency, making them ideal for ambulances, helicopters, and healthcare in remote or rural areas. A rise in demand for home care and step-down services has also led to more usage. The others category encompasses neonatal, anesthesia, and specialty ventilators that fulfill niche yet critical roles in Canadian healthcare. Neonatal ventilators are crucial in tertiary care hospitals that feature dedicated neonatal intensive care units NICUs, showcasing Canada’s focus on maternal and child health.

Canada ventilator market by interface is divided into invasive ventilation and non-invasive ventilation. When categorized by interface, the Canadian ventilators market splits into invasive ventilation and non-invasive ventilation NIV, each catering to different clinical needs. Invasive ventilation remains predominant in acute care environments, especially in ICUs and surgical theaters, where patients need controlled airway management through endotracheal tubes or tracheostomy methods. This sector is closely linked to critical care for trauma, severe infections, neurological conditions, and complex surgical procedures. Healthcare institutions in Canada prioritize patient safety and infection prevention, which drives the demand for invasive ventilators equipped with sophisticated alarm systems, accurate volume and pressure control, and closed-loop ventilation features. However, non-invasive ventilation is rapidly expanding, indicating a transition to less invasive treatment options when clinically appropriate. NIV is commonly utilized for treating sleep apnea, exacerbations of COPD, and chronic respiratory insufficiency, particularly in outpatient, long-term, and home care settings. In Canada, a growing understanding of early treatment and preventive care has facilitated broader use of NIV methods like CPAP and BiPAP. Furthermore, NIV lowers the potential for ventilator-related complications and can reduce hospital lengths of stay, aligning with cost-saving objectives within provincial healthcare systems. The increasing elderly demographic and the rising occurrence of chronic respiratory ailments also bolster long-term demand for both types of interfaces, with NIV gaining noticeable popularity outside conventional hospital environments.

Canada ventilator market by end user is divided into hospitals and clinics, ambulatory surgical centers, home care settings and others. The ventilators market in Canada is categorized by end user into hospitals and clinics, ambulatory surgical centers ASCs, home care environments, and other sectors. Hospitals and clinics make up the largest portion of end users, as they serve as the main facilities for critical care, emergency services, and intricate surgical operations that need ventilatory assistance. Canadian hospitals, especially major urban and educational centers, have modern intensive care units and receive reliable government support, which maintains the demand for high-quality ventilators. Ambulatory surgical centers hold a smaller yet progressively expanding segment, influenced by the nationwide shift towards outpatient and same-day surgeries. ASCs generally employ short-term and anesthesia ventilators that prioritize effectiveness, simplicity, and quick recovery for patients. Home care environments are becoming a significant growth area in Canada, driven by an older population, a rise in chronic respiratory diseases, and governmental efforts to lessen the strain on hospitals. Ventilation at home provides long-term respiratory aid while enhancing patient comfort and living standards. The others category encompasses long-term care homes, rehabilitation facilities, and emergency medical services, all of which are vital components in Canada’s healthcare system. These end users demonstrate a healthcare framework that is increasingly emphasizing decentralization, patient-focused services, and effective use of resources.



"Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031
Aspects covered in this report
• Insulin Delivery Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Intensive Care Ventilators
• Portable/Transport Ventilators
• Others

By Interface
• Invasive Ventilation
• Non-Invasive Ventilation (NIV)

By End User
• Hospitals & Clinics
• Ambulatory Surgical Centers (ASCs)
• Home Care Settings
• Others “